Pharmacokinetics, Tissue Distribution, and Human Serum Albumin Binding Properties of Delicaflavone, a Novel Anti-Tumor Candidate

Delicaflavone (DF), a natural active ingredient from Selaginella doederleinii Hieron, has been reported to have favorable anticancer effects and is thus considered a potential anticancer agent. However, its pharmacokinetics and plasma protein binding properties remain unknown. Here, we investigated...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bing Chen, Hongbin Luo, Weiying Chen, Qishu Huang, Kaifan Zheng, Dafen Xu, Shaoguang Li, Ailin Liu, Liying Huang, Yanjie Zheng, Xinhua Lin, Hong Yao
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/5284f8860df641daaa96a14b61050e52
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5284f8860df641daaa96a14b61050e52
record_format dspace
spelling oai:doaj.org-article:5284f8860df641daaa96a14b61050e522021-11-17T05:46:25ZPharmacokinetics, Tissue Distribution, and Human Serum Albumin Binding Properties of Delicaflavone, a Novel Anti-Tumor Candidate1663-981210.3389/fphar.2021.761884https://doaj.org/article/5284f8860df641daaa96a14b61050e522021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.761884/fullhttps://doaj.org/toc/1663-9812Delicaflavone (DF), a natural active ingredient from Selaginella doederleinii Hieron, has been reported to have favorable anticancer effects and is thus considered a potential anticancer agent. However, its pharmacokinetics and plasma protein binding properties remain unknown. Here, we investigated the pharmacokinetic profile of DF in rats using a validated HPLC-MS/MS methods, as well as its human serum albumin (HSA) binding properties through multi-spectroscopic and in silico methods. The results showed that DF was rapidly eliminated and had a widespread tissue distribution after intravenous administration. DF showed linear dynamics in the dose range of 30–60 mg/kg and poor oral bioavailability. The major distribution tissues of DF were the liver, lungs, and kidneys. Ultraviolet and fluorescence spectroscopy and molecular docking demonstrated that DF had a static quenching effect on HSA, with one binding site, and relatively strong binding constants. Thermodynamic analysis of the binding data revealed that hydrogen bonding and van der Waals interactions played major roles in binding. The results of this study further our understanding of the pharmacokinetic and plasma protein binding properties of the potential anticancer agent DF and shed light on pharmacological strategies that may be useful for the development of novel cancer therapeutics.Bing ChenBing ChenHongbin LuoHongbin LuoWeiying ChenWeiying ChenQishu HuangKaifan ZhengDafen XuShaoguang LiAilin LiuLiying HuangYanjie ZhengXinhua LinXinhua LinHong YaoHong YaoFrontiers Media S.A.articledelicaflavonepharmacokineticstissue distributionhuman serum albuminplasma binding propertyantitumor candidate 2Therapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic delicaflavone
pharmacokinetics
tissue distribution
human serum albumin
plasma binding property
antitumor candidate 2
Therapeutics. Pharmacology
RM1-950
spellingShingle delicaflavone
pharmacokinetics
tissue distribution
human serum albumin
plasma binding property
antitumor candidate 2
Therapeutics. Pharmacology
RM1-950
Bing Chen
Bing Chen
Hongbin Luo
Hongbin Luo
Weiying Chen
Weiying Chen
Qishu Huang
Kaifan Zheng
Dafen Xu
Shaoguang Li
Ailin Liu
Liying Huang
Yanjie Zheng
Xinhua Lin
Xinhua Lin
Hong Yao
Hong Yao
Pharmacokinetics, Tissue Distribution, and Human Serum Albumin Binding Properties of Delicaflavone, a Novel Anti-Tumor Candidate
description Delicaflavone (DF), a natural active ingredient from Selaginella doederleinii Hieron, has been reported to have favorable anticancer effects and is thus considered a potential anticancer agent. However, its pharmacokinetics and plasma protein binding properties remain unknown. Here, we investigated the pharmacokinetic profile of DF in rats using a validated HPLC-MS/MS methods, as well as its human serum albumin (HSA) binding properties through multi-spectroscopic and in silico methods. The results showed that DF was rapidly eliminated and had a widespread tissue distribution after intravenous administration. DF showed linear dynamics in the dose range of 30–60 mg/kg and poor oral bioavailability. The major distribution tissues of DF were the liver, lungs, and kidneys. Ultraviolet and fluorescence spectroscopy and molecular docking demonstrated that DF had a static quenching effect on HSA, with one binding site, and relatively strong binding constants. Thermodynamic analysis of the binding data revealed that hydrogen bonding and van der Waals interactions played major roles in binding. The results of this study further our understanding of the pharmacokinetic and plasma protein binding properties of the potential anticancer agent DF and shed light on pharmacological strategies that may be useful for the development of novel cancer therapeutics.
format article
author Bing Chen
Bing Chen
Hongbin Luo
Hongbin Luo
Weiying Chen
Weiying Chen
Qishu Huang
Kaifan Zheng
Dafen Xu
Shaoguang Li
Ailin Liu
Liying Huang
Yanjie Zheng
Xinhua Lin
Xinhua Lin
Hong Yao
Hong Yao
author_facet Bing Chen
Bing Chen
Hongbin Luo
Hongbin Luo
Weiying Chen
Weiying Chen
Qishu Huang
Kaifan Zheng
Dafen Xu
Shaoguang Li
Ailin Liu
Liying Huang
Yanjie Zheng
Xinhua Lin
Xinhua Lin
Hong Yao
Hong Yao
author_sort Bing Chen
title Pharmacokinetics, Tissue Distribution, and Human Serum Albumin Binding Properties of Delicaflavone, a Novel Anti-Tumor Candidate
title_short Pharmacokinetics, Tissue Distribution, and Human Serum Albumin Binding Properties of Delicaflavone, a Novel Anti-Tumor Candidate
title_full Pharmacokinetics, Tissue Distribution, and Human Serum Albumin Binding Properties of Delicaflavone, a Novel Anti-Tumor Candidate
title_fullStr Pharmacokinetics, Tissue Distribution, and Human Serum Albumin Binding Properties of Delicaflavone, a Novel Anti-Tumor Candidate
title_full_unstemmed Pharmacokinetics, Tissue Distribution, and Human Serum Albumin Binding Properties of Delicaflavone, a Novel Anti-Tumor Candidate
title_sort pharmacokinetics, tissue distribution, and human serum albumin binding properties of delicaflavone, a novel anti-tumor candidate
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/5284f8860df641daaa96a14b61050e52
work_keys_str_mv AT bingchen pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
AT bingchen pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
AT hongbinluo pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
AT hongbinluo pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
AT weiyingchen pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
AT weiyingchen pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
AT qishuhuang pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
AT kaifanzheng pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
AT dafenxu pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
AT shaoguangli pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
AT ailinliu pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
AT liyinghuang pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
AT yanjiezheng pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
AT xinhualin pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
AT xinhualin pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
AT hongyao pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
AT hongyao pharmacokineticstissuedistributionandhumanserumalbuminbindingpropertiesofdelicaflavoneanovelantitumorcandidate
_version_ 1718425857785069568